AgeX Therapeutics Competitors and Similar CompaniesClear all
AgeX Therapeutics's competitors and similar companies include Right To Care, Acorda Therapeutics, Polyplus-transfection and VCANBIO.
 AgeX Therapeutics AgeX Therapeutics is a company focused on the development and commercialization of therapeutics targeting human aging. |  Right To Care Right To Care is a non-profit organization that supports and delivers prevention, care, and treatment for HIV and associated diseases in South Africa. |  Acorda Therapeutics Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. |  Polyplus-transfection Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics. |  VCANBIO VCANBIO Cell & Gene Engineering (also known as Zhongyuan Union) is a biotech company that offers health management services and products. | |
Founding Date | Founding Date 2017 | Founding Date 2001 | Founding Date 1995 | Founding Date 2002 | Founding Date 1993 |
Type | Type Public | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Alameda, US HQ Alameda, US | Locations Ardsley, US HQ Chelsea, US South San Francisco, US Waltham, US | Locations Illkirch-Graffenstaden, FR HQ New York, US | Locations Tianjin, CN HQ | |
Employees | Employees N/A | Employees 1,817 | Employees 4742% decrease | Employees 1133% increase | Employees 2,0149% decrease |
Valuation ($) | Valuation ($) 27.8 m | Valuation ($) N/A | Valuation ($) 821 k | Valuation ($) N/A | Valuation ($) 1.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $130k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $117.6m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) ¥1.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $15.3m (FY, 2023) | Cost of goods N/A | Cost of goods ¥438.8m (FY, 2025) |
Net income | Net income ($19.2m) (FY, 2025) | Net income N/A | Net income ($252.9m) (FY, 2023) | Net income N/A | Net income ¥103.5m (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 63.8m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 3.2m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Right To Care
HQ
Centurion, ZA
Employees
1,817
Right To Care is a non-profit organization that supports and delivers prevention, care, and treatment for HIV and associated diseases in South Africa.
View companyAcorda Therapeutics
HQ
Ardsley, US
Employees
474↓ 2% decrease
Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.
View companyPolyplus-transfection
HQ
Illkirch-Graffenstaden, FR
Employees
113↑ 3% increase
Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics.
View companyVCANBIO
HQ
Tianjin, CN
Employees
2,014↓ 9% decrease
VCANBIO Cell & Gene Engineering (also known as Zhongyuan Union) is a biotech company that offers health management services and products.
View company